secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eikon Therapeutics, Inc. (EIKN)
CIK:        0001861123
Form:       8-K
Filed at:   2026-02-06T23:59:59+00:00
Accession:  0001193125-26-041201
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Eikon adopts amended charter and bylaws upon IPO closing on Feb 6, 2026
-----------------------------------------------------------------------

- IPO of common stock closed on February 6, 2026 per the company's S-1 registration.
- Amended and restated certificate of incorporation filed with Delaware Secretary of State.
- Amended and restated bylaws adopted effective as of February 6, 2026.
- Both documents were previously approved by the board and stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861123/000119312526041201/0001193125-26-041201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861123/000119312526041201/d49647d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-041201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer